Corpus GrippeCanadaV3

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013.

Identifieur interne : 000214 ( Main/Exploration ); précédent : 000213; suivant : 000215

Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013.

Auteurs : Todd F. Hatchette ; B Lynn Johnston ; Emily Schleihauf ; Angela Mask ; David Haldane ; Michael Drebot ; Maureen Baikie ; Teri J. Cole ; Sarah Fleming ; Richard Gould ; Robbin Lindsay

Source :

RBID : pubmed:26401788

Descripteurs français

English descriptors

Abstract

Ixodes scapularis ticks, which transmit Borrelia burgdorferi, the causative agent of Lyme disease (LD), are endemic to at least 6 regions of Nova Scotia, Canada. To assess the epidemiology and prevalence of LD in Nova Scotia, we analyzed data from 329 persons with LD reported in Nova Scotia during 2002-2013. Most patients reported symptoms of early localized infection with rash (89.7%), influenza-like illness (69.6%), or both; clinician-diagnosed erythema migrans was documented for 53.2%. In a separate serosurvey, of 1,855 serum samples screened for antibodies to B. burgdorferi, 2 were borderline positive (both with an indeterminate IgG on Western blot), resulting in an estimated seroprevalence of 0.14% (95% CI 0.02%-0.51%). Although LD incidence in Nova Scotia has risen sharply since 2002 and is the highest in Canada (16/100,000 population in 2013), the estimated number of residents with evidence of infection is low, and risk is localized to currently identified LD-endemic regions.

DOI: 10.3201/eid2110.141640
PubMed: 26401788


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013.</title>
<author>
<name sortKey="Hatchette, Todd F" sort="Hatchette, Todd F" uniqKey="Hatchette T" first="Todd F" last="Hatchette">Todd F. Hatchette</name>
</author>
<author>
<name sortKey="Johnston, B Lynn" sort="Johnston, B Lynn" uniqKey="Johnston B" first="B Lynn" last="Johnston">B Lynn Johnston</name>
</author>
<author>
<name sortKey="Schleihauf, Emily" sort="Schleihauf, Emily" uniqKey="Schleihauf E" first="Emily" last="Schleihauf">Emily Schleihauf</name>
</author>
<author>
<name sortKey="Mask, Angela" sort="Mask, Angela" uniqKey="Mask A" first="Angela" last="Mask">Angela Mask</name>
</author>
<author>
<name sortKey="Haldane, David" sort="Haldane, David" uniqKey="Haldane D" first="David" last="Haldane">David Haldane</name>
</author>
<author>
<name sortKey="Drebot, Michael" sort="Drebot, Michael" uniqKey="Drebot M" first="Michael" last="Drebot">Michael Drebot</name>
</author>
<author>
<name sortKey="Baikie, Maureen" sort="Baikie, Maureen" uniqKey="Baikie M" first="Maureen" last="Baikie">Maureen Baikie</name>
</author>
<author>
<name sortKey="Cole, Teri J" sort="Cole, Teri J" uniqKey="Cole T" first="Teri J" last="Cole">Teri J. Cole</name>
</author>
<author>
<name sortKey="Fleming, Sarah" sort="Fleming, Sarah" uniqKey="Fleming S" first="Sarah" last="Fleming">Sarah Fleming</name>
</author>
<author>
<name sortKey="Gould, Richard" sort="Gould, Richard" uniqKey="Gould R" first="Richard" last="Gould">Richard Gould</name>
</author>
<author>
<name sortKey="Lindsay, Robbin" sort="Lindsay, Robbin" uniqKey="Lindsay R" first="Robbin" last="Lindsay">Robbin Lindsay</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26401788</idno>
<idno type="pmid">26401788</idno>
<idno type="doi">10.3201/eid2110.141640</idno>
<idno type="wicri:Area/Main/Corpus">000180</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000180</idno>
<idno type="wicri:Area/Main/Curation">000180</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000180</idno>
<idno type="wicri:Area/Main/Exploration">000180</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013.</title>
<author>
<name sortKey="Hatchette, Todd F" sort="Hatchette, Todd F" uniqKey="Hatchette T" first="Todd F" last="Hatchette">Todd F. Hatchette</name>
</author>
<author>
<name sortKey="Johnston, B Lynn" sort="Johnston, B Lynn" uniqKey="Johnston B" first="B Lynn" last="Johnston">B Lynn Johnston</name>
</author>
<author>
<name sortKey="Schleihauf, Emily" sort="Schleihauf, Emily" uniqKey="Schleihauf E" first="Emily" last="Schleihauf">Emily Schleihauf</name>
</author>
<author>
<name sortKey="Mask, Angela" sort="Mask, Angela" uniqKey="Mask A" first="Angela" last="Mask">Angela Mask</name>
</author>
<author>
<name sortKey="Haldane, David" sort="Haldane, David" uniqKey="Haldane D" first="David" last="Haldane">David Haldane</name>
</author>
<author>
<name sortKey="Drebot, Michael" sort="Drebot, Michael" uniqKey="Drebot M" first="Michael" last="Drebot">Michael Drebot</name>
</author>
<author>
<name sortKey="Baikie, Maureen" sort="Baikie, Maureen" uniqKey="Baikie M" first="Maureen" last="Baikie">Maureen Baikie</name>
</author>
<author>
<name sortKey="Cole, Teri J" sort="Cole, Teri J" uniqKey="Cole T" first="Teri J" last="Cole">Teri J. Cole</name>
</author>
<author>
<name sortKey="Fleming, Sarah" sort="Fleming, Sarah" uniqKey="Fleming S" first="Sarah" last="Fleming">Sarah Fleming</name>
</author>
<author>
<name sortKey="Gould, Richard" sort="Gould, Richard" uniqKey="Gould R" first="Richard" last="Gould">Richard Gould</name>
</author>
<author>
<name sortKey="Lindsay, Robbin" sort="Lindsay, Robbin" uniqKey="Lindsay R" first="Robbin" last="Lindsay">Robbin Lindsay</name>
</author>
</analytic>
<series>
<title level="j">Emerging infectious diseases</title>
<idno type="eISSN">1080-6059</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Borrelia burgdorferi (isolation & purification)</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Disease Vectors</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Ixodes (parasitology)</term>
<term>Ixodes (pathogenicity)</term>
<term>Lyme Disease (diagnosis)</term>
<term>Lyme Disease (epidemiology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nova Scotia (epidemiology)</term>
<term>Seroepidemiologic Studies</term>
<term>Ticks</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Borrelia burgdorferi (isolement et purification)</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Ixodes (parasitologie)</term>
<term>Ixodes (pathogénicité)</term>
<term>Maladie de Lyme (diagnostic)</term>
<term>Maladie de Lyme (épidémiologie)</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouvelle-Écosse (épidémiologie)</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tiques</term>
<term>Vecteurs de maladie</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Nova Scotia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Lyme Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Maladie de Lyme</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Lyme Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Borrelia burgdorferi</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Borrelia burgdorferi</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr">
<term>Ixodes</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en">
<term>Ixodes</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Ixodes</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Ixodes</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Maladie de Lyme</term>
<term>Nouvelle-Écosse</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Disease Vectors</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Seroepidemiologic Studies</term>
<term>Ticks</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tiques</term>
<term>Vecteurs de maladie</term>
<term>Études séroépidémiologiques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Ixodes scapularis ticks, which transmit Borrelia burgdorferi, the causative agent of Lyme disease (LD), are endemic to at least 6 regions of Nova Scotia, Canada. To assess the epidemiology and prevalence of LD in Nova Scotia, we analyzed data from 329 persons with LD reported in Nova Scotia during 2002-2013. Most patients reported symptoms of early localized infection with rash (89.7%), influenza-like illness (69.6%), or both; clinician-diagnosed erythema migrans was documented for 53.2%. In a separate serosurvey, of 1,855 serum samples screened for antibodies to B. burgdorferi, 2 were borderline positive (both with an indeterminate IgG on Western blot), resulting in an estimated seroprevalence of 0.14% (95% CI 0.02%-0.51%). Although LD incidence in Nova Scotia has risen sharply since 2002 and is the highest in Canada (16/100,000 population in 2013), the estimated number of residents with evidence of infection is low, and risk is localized to currently identified LD-endemic regions. </div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26401788</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>05</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>01</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1080-6059</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>21</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Emerging infectious diseases</Title>
<ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013.</ArticleTitle>
<Pagination>
<MedlinePgn>1751-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2110.141640</ELocationID>
<Abstract>
<AbstractText>Ixodes scapularis ticks, which transmit Borrelia burgdorferi, the causative agent of Lyme disease (LD), are endemic to at least 6 regions of Nova Scotia, Canada. To assess the epidemiology and prevalence of LD in Nova Scotia, we analyzed data from 329 persons with LD reported in Nova Scotia during 2002-2013. Most patients reported symptoms of early localized infection with rash (89.7%), influenza-like illness (69.6%), or both; clinician-diagnosed erythema migrans was documented for 53.2%. In a separate serosurvey, of 1,855 serum samples screened for antibodies to B. burgdorferi, 2 were borderline positive (both with an indeterminate IgG on Western blot), resulting in an estimated seroprevalence of 0.14% (95% CI 0.02%-0.51%). Although LD incidence in Nova Scotia has risen sharply since 2002 and is the highest in Canada (16/100,000 population in 2013), the estimated number of residents with evidence of infection is low, and risk is localized to currently identified LD-endemic regions. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hatchette</LastName>
<ForeName>Todd F</ForeName>
<Initials>TF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Johnston</LastName>
<ForeName>B Lynn</ForeName>
<Initials>BL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schleihauf</LastName>
<ForeName>Emily</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mask</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Haldane</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Drebot</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Baikie</LastName>
<ForeName>Maureen</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cole</LastName>
<ForeName>Teri J</ForeName>
<Initials>TJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fleming</LastName>
<ForeName>Sarah</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gould</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lindsay</LastName>
<ForeName>Robbin</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Emerg Infect Dis</MedlineTA>
<NlmUniqueID>9508155</NlmUniqueID>
<ISSNLinking>1080-6040</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D025065" MajorTopicYN="N">Borrelia burgdorferi</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004199" MajorTopicYN="N">Disease Vectors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018884" MajorTopicYN="N">Ixodes</DescriptorName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008193" MajorTopicYN="N">Lyme Disease</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009674" MajorTopicYN="N" Type="Geographic">Nova Scotia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013987" MajorTopicYN="N">Ticks</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Borrelia burgdorferi</Keyword>
<Keyword MajorTopicYN="N">Canada</Keyword>
<Keyword MajorTopicYN="N">Lyme disease</Keyword>
<Keyword MajorTopicYN="N">Nova Scotia</Keyword>
<Keyword MajorTopicYN="N">epidemiology</Keyword>
<Keyword MajorTopicYN="N">seroprevalence</Keyword>
<Keyword MajorTopicYN="N">ticks</Keyword>
<Keyword MajorTopicYN="N">vector-borne infections</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>9</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>5</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26401788</ArticleId>
<ArticleId IdType="doi">10.3201/eid2110.141640</ArticleId>
<ArticleId IdType="pmc">PMC4593424</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Int J Epidemiol. 2000 Apr;29(2):362-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10817137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2002 Aug 19;20(25-26):3130-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12163264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2003 Jun 12;348(24):2472-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12802042</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2003 Aug 15;37(4):528-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12905137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2006 Nov 1;43(9):1089-134</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17029130</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2008 Jul 15;47(2):188-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18532885</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Surveill Summ. 2008 Oct 3;57(10):1-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18830214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Can J Infect Dis Med Microbiol. 2007 Mar;18(2):145-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18923770</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Dermatol. 2008;9(6):355-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18973402</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2009 Mar;123(3):959-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19255026</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2010 Feb 15;50(4):512-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20070237</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Rheumatol. 2010 May;37(5):1049-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20360182</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CMAJ. 1991 Jun 15;144(12):1627-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2054769</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vector Borne Zoonotic Dis. 2011 Jul;11(7):863-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21413887</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2011 Sep;53(6):541-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21865190</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diagn Microbiol Infect Dis. 2013 Jan;75(1):9-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23062467</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2013 Jan 17;368(3):291-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23323920</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Care Res (Hoboken). 2013 Dec;65(12):1986-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23925915</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2013 Sep 18;310(11):1110</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24045727</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2013 Dec;51(12):4045-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24068010</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2014 Mar;20(3):493-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24565119</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Parasit Vectors. 2014 Apr 15;7:183</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24731287</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2014 May 1;370(18):1724-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24785207</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Yale J Biol Med. 1989 May-Jun;62(3):253-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2683415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Can Commun Dis Rep. 2014 Mar 06;40(5):74-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29769885</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 1987 Nov;107(5):725-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3662285</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 1986 Aug;154(2):295-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3722867</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 1984 Oct;150(4):489-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6386994</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):590-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7623762</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med. 1995 Apr 24;98(4A):15S-23S; discussion 23S-24S</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7726187</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 1996 Jan;34(1):1-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8748261</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Baikie, Maureen" sort="Baikie, Maureen" uniqKey="Baikie M" first="Maureen" last="Baikie">Maureen Baikie</name>
<name sortKey="Cole, Teri J" sort="Cole, Teri J" uniqKey="Cole T" first="Teri J" last="Cole">Teri J. Cole</name>
<name sortKey="Drebot, Michael" sort="Drebot, Michael" uniqKey="Drebot M" first="Michael" last="Drebot">Michael Drebot</name>
<name sortKey="Fleming, Sarah" sort="Fleming, Sarah" uniqKey="Fleming S" first="Sarah" last="Fleming">Sarah Fleming</name>
<name sortKey="Gould, Richard" sort="Gould, Richard" uniqKey="Gould R" first="Richard" last="Gould">Richard Gould</name>
<name sortKey="Haldane, David" sort="Haldane, David" uniqKey="Haldane D" first="David" last="Haldane">David Haldane</name>
<name sortKey="Hatchette, Todd F" sort="Hatchette, Todd F" uniqKey="Hatchette T" first="Todd F" last="Hatchette">Todd F. Hatchette</name>
<name sortKey="Johnston, B Lynn" sort="Johnston, B Lynn" uniqKey="Johnston B" first="B Lynn" last="Johnston">B Lynn Johnston</name>
<name sortKey="Lindsay, Robbin" sort="Lindsay, Robbin" uniqKey="Lindsay R" first="Robbin" last="Lindsay">Robbin Lindsay</name>
<name sortKey="Mask, Angela" sort="Mask, Angela" uniqKey="Mask A" first="Angela" last="Mask">Angela Mask</name>
<name sortKey="Schleihauf, Emily" sort="Schleihauf, Emily" uniqKey="Schleihauf E" first="Emily" last="Schleihauf">Emily Schleihauf</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000214 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000214 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26401788
   |texte=   Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26401788" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020